
NEWSFLOW
MGC Pharmaceuticals (#MXC) – quarterly report shows further net cash outflows and drawing of death spiral financing
- 2023-01-30 07:40:42
I have warned you for a long time, notably with this dossier HERE, that Standard Listed MGC Pharmaceuticals (MXC) is a dog with fleas drowning in a sea of red flags. Today’s quarterlies, coming after six ramptastic announcements so far this month are piss poor and written with intent to deceive.
Following the publication of my red flag dossier earlier this year, anyone owning shares in MGC Pharmaceuticals (MXC) was fully warned of the need to lube up. I hope they did. The shares were 2.25p back on 11 January when I warned you that this was a £70 million dog from the scholars and gentleman at Turner Pope. They are now just 0.825p but after another red flag admission today they are still a monstrous sell.
The numbers for the year to June 30 came out last Thursday. Forgive my delayed response but suffice to say that MGC (MXC) engaged in industrial scale turd polishing.